Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
JAMA Ophthalmology
Published October 15, 2026
Variables Associated With Faricimab Treatment Durability in Neovascular Age-Related Macular Degen...
October 16, 2026
Medspoke
Medspoke
JAMA Oncology
Published October 15, 2026
00:00
--:--
Nivolumab-Ipilimumab for Localized Microsatellite Instability-High Gastric/Gastroesophageal Junct...
October 16, 2026
Share
Nivolumab-Ipilimumab for Localized Microsatellite Instability-High Gastric/Gastroesophageal Junction Adenocarcinoma: The Phase 2 NEONIPIGA Nonrandomized Clinical Trial.
https://www.medspoke.co/channel_journal?id=785&tap_id=15702
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
HemaSphere
Published October 13, 2026
Immune and cellular determinants of response to HMA-venetoclax regimens in acute myeloid leukemia.
October 15, 2026
Why are you reporting this TALK?
